AVTR Stock Analysis: Buy, Sell, or Hold?

AVTR - Avantor, Inc.

LABORATORY ANALYTICAL INSTRUMENTS
$10.92
0.11 (1.02%) ▲
HOLD
LOW Confidence
Protect Your AVTR Gains
Last Updated: January 30, 2026
Earnings: Feb 11, 2026 11d

Get Alerted When AVTR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: AVTR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$13.21
Based on 2.6% avg growth
INTRINSIC VALUE TODAY
$8.20
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.8x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: AVTR is currently trading at $10.92, which is considered oversold relative to its 30-day fair value range of $11.27 to $12.24. The stock's valuation (Forward PE: 11.9) is in line with its historical norms (12.8). Remarkably, the market is currently pricing in an annual earnings decline of 2.6% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, AVTR is in a downtrend. The price is currently testing key support at $10.67. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.04 (+20.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $11.27 - $12.24
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 79.5%

Protect Your Profits

Holding AVTR? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 20.6% below Wall St target ($13.04)
  • CAUTION: Recommendation downgraded due to -7.5% 5-day decline

Fair Price Analysis

30-Day Fair Range $11.27 - $12.24
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $10.67
Resistance Level $12.51
Current Trend Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 11.88
Wall Street Target $13.04 (+20.6%)
Revenue Growth (YoY) -5.3%
Earnings Growth (YoY) -34.2%
Profit Margin -1.2%
Valuation Discount vs History -2.6% cheaper
PE vs Historical 11.9 vs 12.8 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -2.6% (market-implied from PE analysis)
1-Year Target $10.53 (-3%)
2-Year Target $10.26 (-5%)
3-Year Target $9.99 (-8%)
3-Yr Target (if PE normalizes) (PE: 12→13) $10.76 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: 1.1%) $20.95 (+94%)
Base: (SPY PE: 11.9, Growth: 1.1%) $11.16 (+3%)
Bear: (PE: 10.1, Growth: 1.1%) $9.49 (-12%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.9 to 12.8
Stabilization Target: $11.65 (+7.8%)
PE Expansion Potential: +7.8%
Last updated: January 30, 2026 5:52 PM ET
Data refreshes hourly during market hours. Next update: 6:52 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Gilbert Ray Cisneros, Jr. SELL 2025-08-13
Gilbert Ray Cisneros, Jr. SELL 2025-08-12
Steven W Eck SELL 3476 shares 2025-08-05

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALC
Alcon AG
STRONG BUY
27 analysts
$92 63 BUY
ISRG
Intuitive Surgical Inc
BUY
33 analysts
$608 58 HOLD
RGEN
Repligen Corporation
STRONG BUY
19 analysts
$191 58 HOLD
RMD
ResMed Inc
BUY
19 analysts
$292 57 HOLD
ALGN
Align Technology Inc
BUY
18 analysts
$184 62 BUY

Advanced AVTR Option Strategies

Professional options setups generated by AI based on today's AVTR price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for AVTR

AVTR Technical Chart AVTR Price Prediction AVTR Earnings Date AVTR Investment Advisor AVTR Fair Price Analyzer AVTR Options Advisor AVTR Options Chain AVTR Options Analysis AVTR Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals